In clinical trials of chronic diseases such as acquired immunodeficiency syndrome, cancer, or cardiovascular diseases, the concept of quality-adjusted lifetime (QAL) has received more and more attention. In this paper, we consider the problem of how the covariates affect the mean QAL when the data are subject to right censoring. We allow a very general form for the mean model as a function of covariates. Using the idea of inverse probability weighting, we first construct a simple weighted estimating equation for the parameters in our mean model. We then find the form of the most efficient estimating equation, which yields the most efficient estimator for the regression parameters. Since the most efficient estimator depends on the distribution of the health history processes, and thus cannot be estimated nonparametrically, we consider different approaches for improving the efficiency of the simple weighted estimating equation using observed data. The applicability of these methods is demonstrated by both simulation experiments and a data example from a breast cancer clinical trial study.
INTRODUCTION
In studies that evaluate new therapies for chronic diseases such as cancer, acquired immunodeficiency syndrome, or cardiovascular diseases, extending overall survival time may not be the only goal. Improving patients' quality of life is also important. Quality-adjusted lifetime (QAL) is a measure which combines patients' quality of life and survival time together and provides a useful summary for evaluating the treatment effect.
QAL has been studied by Goldhirsch and others (1989) , Glasziou and others (1990) , and Gelber and others (1995) . In their work, a patient's health history is partitioned into different health states, e.g.
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The regression model and assumptions
For the ith individual in the study, let the health history process be represented by {V i (t), t 0 i = 1, . . . , n}. V can include information on both discrete and continuous variables. Denote V H i (t) = {V i (u) : u t}, the health history up to time t. Let T i be the survival time and q be a known utility function mapping V i (t) to the interval [0, 1] ; q is assumed to be known for our purpose. In Section 5, we discuss how to handle the situation when q is not known to us. The ith individual's QAL, denoted as Q i , is equal to
Denote the ith individual's censoring time by C i . Censoring is assumed to be independent of the health history process V i (·). The survival distribution of C is denoted as K (t) = Pr(C > t). Because of censoring, we cannot make inference on QAL over the entire health history; we only consider the QAL accumulated within a time limit L, which is chosen based on the study duration. In most cases, we would like to choose L as large as possible but not to exceed a limit beyond which few data are available to us. Consequently, the survival time of an individual will be truncated at L, that is, T L = min(T, L). For ease of notation, we still use T instead of T L . We assume that Pr(C L) > 0.
Let Z i denote the ( p + 1) × 1 vector of covariates associated with the ith individual, with the first covariate being the constant 1. The observed data for n individuals are the independently and identically distributed random quantities:
. . , n]. According to this definition, Q i = Q i {min(T i , L)}.
We describe the mean QAL as a function of the covariates of the form:
where β is a ( p + 1) × 1 vector of parameters of interest. Special cases include g(β, Z i ) = β Z i , a linear regression model LRG and g(β, Z i ) = g(β Z i ), a generalized LRG. Our goal is to make inference about β in the mean model (2.1) for some pre-specified function g from the observed censored quality of life and survival data.
Simple weighted estimating equation
If complete data are observed, a consistent estimatorβ for β in the mean model (2.1) can be obtained from the following estimating equation:
where h(Z i ) is ( p + 1)-dimensional vector of functions of Z i , and the superscript F represents models for full data. From the semi-parametric theory (Robins and Rotnitzky, 1992) , we know that the most efficient estimating equation for the complete data case is the one with
where β 0 is the true value of the parameters.
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In the special case of a linear model where g(β, Z i ) = β Z i and Var(Q i |Z i ) is assumed to be a constant, the most efficient estimating equation is obtained by setting h F eff (Z i ) = Z i , and hence
This equation is the same as the ordinary least squares estimating equation for the LRGs.
When censoring is present, Q i cannot be observed for everybody so the estimating equation (2.2) cannot be used. However, using the idea of inverse probability weighting, which was originally proposed by Horvitz and Thompson (1952) , we can construct a simple weighted estimating equation for β in our mean model (2.1) with censored data:
where
is the survival probability for the censoring variable C at time T i . The consistency of the simple weighted estimating equation is shown by
Since K (T i ) is not known to us, we can estimate it using the Kaplan-Meier estimator K (T i ) (Kaplan and Meier, 1958) . Hence, our simple weighted estimating equation becomes
In the special case when g(β, Z i ) = β Z i and h(Z i ) = Z i , the estimating equation (2.3) has a closedform solution for β given byβ
where we use the notation a ⊗2 = aa , a ⊗ b = ab , for vectors a and b. The simple weighted estimator is easy to calculate, however, only the QAL for the subjects with observed failures are used in the estimating equation. Therefore, it cannot be efficient. 
Efficiency study
To develop the theory on efficiency study of the estimating equations, we use the counting processes and the associated martingale theory as described by Fleming and Harrington (1991) . Let the filtration F(u) be the increasing sequence of σ -algebras generated by
We consider the martingale process
is the hazard function for the censoring distribution.
From the semi-parametric theory for missing data processes developed by Robins and Rotnitzky (1992) and Robins and others (1994) , the influence function for the estimating equation for any regular asymptotic linear (RAL) estimators of β 0 can be written as
and e{V H i (u)} is any ( p + 1)-dimensional vector of functionals of the health history V H i (u). It should be noted that the influence function for the simple weighted estimating equation (2.3) is simply the first two terms of (2.4) (Zhao and Tsiatis, 1997, equation A.7) .
From Robins and Rotnitzky (1992) , the most efficient estimating equation is obtained by choosing
From the above results, the most efficient estimating equation can be formed by
is a consistent estimator for G (W, u) , for any functional W. In theory, the asymptotic variance ofβ from solving (2.6) should achieve the semi-parametric efficiency bound, which means thatβ from (2.6) has the smallest variance among the class of all regular asymptotically linear estimators. However, it is not useful to use (2.6) for data analysis, since e eff and h eff depend on the unknown true population parameters which are difficult to estimate nonparametrically.
Improved estimating equation
Due to the difficulty in obtaining the most efficient estimating equation nonparametrically, we wish to find an estimating equation which can be obtained from the observed data, and which can be more efficient than the simple weighted estimating equation for any choice of h(Z ). In the subsequent section, we will discuss the issues of choosing h(Z ).
The best-coefficient approach. We first consider a method for obtaining the improved estimating equation, which is similar to the approach appeared in Zhao and Tsiatis (1999) for obtaining improved estimators of mean QAL, and in Bang and Tsiatis (2002) for median regression of medical costs. We will call this approach the best-coefficient approach and denote it as BC. For any chosen e{V H i (u)}, if we multiply the third term in (2.4) by a constant
where is equal to Cov(W 1 , W 2 )Var(W 2 ) −1 , with W 1 and W 2 being the second and third terms in (2.4), i.e.
,
then the variance of this influence function (2.7) will always be smaller than that of the simple weighted estimating equation. In practice, is not known, so it has to be estimated from available data, which will result in some additional variability for finite sample sizes. We will examine its finite sample performance in our simulation study. We can derive an explicit formula for the BC estimator in the special case when g(β, Z ) = β Z and
, for example, we can get
where 
The detail of the derivation is given in the Appendix.
The improved estimating equation with = 1 and Q i (u) in place of E{Q i |V H i (u)}. Our second strategy is to choose = 1, and use Q i (u) in place of E{Q i |V H i (u)} in the formula for e eff {V H i (u)}, i.e. we choose
The corresponding estimating equation, named the improved estimating equation and denoted as IMP, has the following form:
This estimating equation (2.10) is not guaranteed to be always more efficient than the simple weighted estimating equation (2.3). However, due to the usual correlation between Q i (u) and E{Q i |V H i (u)}, we expect this estimator to perform well in most realistic settings.
In the case when g(β, Z ) = β Z and h(Z ) = Z , this improved estimator has an explicit formβ IMP = C −1 1 C 2 , where
The estimating equation using regression approach. Our last strategy for improving efficiency is to choose = 1 and estimate E{Q i |V H i (u)} by regressing
on observed covariates, using only those observations with X i u (Robins and Rotnitzky, 1992) . The resulting estimating equation will be in the same form as (2.10) except that Q i (u) is replaced by the estimate of E{Q i |V H i (u)} from the regression approach.
To implement this idea, we may choose an LRG, regressing
on some covariates that are predictive of QAL; or we may use a generalized additive model (Hastie and Tibshirani, 1990; Van der Laan and Hubbard, 1999) , which accommodates a nonparametric regression of
on some functions of the health history process V H i (u), e.g. Q i (u). We will compare the performance of these choices in our simulation studies.
Choice of h(Z )
Compared to the best choice of h(Z ) for the complete data case
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where P(Z i ) is defined as (2.5). It is equivalent to down-weight the influence of Var(Q i |Z i ), due to the added uncertainty about the variance of Q i given Z i for the censored observation. Since it is harder to estimate the second moment than the first moment given the high dimensional health history process, and secondly, using an incorrect model could potentially increase the variability of the estimating equation, we choose not to attempt to estimate P(Z i ) and use instead the best choice of h(Z ) for the complete data case.
Variance estimators for regression parameters
In this section, we derive the variance estimators for the regression parameters in our various estimating equations. Supposeβ is the solution to an estimating equation and β 0 is the true value of the parameters. From Taylor's expansion, we have
In the special case when g(β, Z ) = β Z and h(Z ) = Z , we have
Based on the general influence function (2.4), I 1 is equal to
where Using derivations similar to those in the Appendix, we can show that for large n, I 1 , the asymptotic variance of n
where .3) is just the first two terms in (2.12). Due to the special coefficient used in the BC estimating equation (2.7), its variance can be easily shown to be
SIMULATION EXPERIMENTS
In this section, we conduct some simulation experiments to evaluate our proposed estimating equations for the parameters in the regression models. Similar to the IBCSG Trial V example which is to be presented in Section 4, we consider patients entering the study first experiencing toxicity for a certain time, then a period of good health (TWiST), then their disease relapse followed by death. We use TOX to represent the time from the treatment initiation to end of toxicity, TR the time from treatment initiation to disease relapse, and OS the time from treatment initiation to death. The QAL is defined as:
where q TOX is the utility coefficient for TOX, q REL the utility coefficient for the REL (the period between disease relapse and death). The utility coefficient for TWiST is assumed to be 1, and q TOX = q REL = q = 0.5. We generate 5000 simulations, each consisting of two groups of censored health status data with sample sizes varying from 100 to 400 for each group. Two scenarios are considered here. In the first scenario, TOX is uniformly distributed on [0, T 1 ] for group 1 (T 1 = 60) and uniformly distributed on [0, T 2 ] for group 2 (T 2 = 80); TR is exponentially distributed with hazard λ 1 = 1/130 for group 1 and hazard λ 2 = 1/90 for group 2, and both are truncated at L 1 = 81. OS is exponentially distributed with hazard λ 3 = 1/140 and truncated at L 2 = 100 for both groups. The censoring variables for both groups are uniform on [70, 116] and are independent of TOX, TR, and OS, which results in the amount of censoring to be about 35% for group 1 and 36% for group 2. For each group, if TR is greater than OS, we set TR = OS. Similarly, if TOX is greater than TR, we set TOX = TR. The true mean QAL for group k (k = 1, 2) is
Plugging in the parameter values, we can obtain that the true mean QAL is 47.91 for group 1 and 43.89 for group 2. Using an LRG with treatment as a covariate, and group 2 as the reference group, the intercept and slope parameters in our regression model are 43.89 and 4.02, respectively. In the second scenario, group 2 is generated the same way as group 1 in the first scenario, resulting in an intercept of 47.91 and a slope of 0.
We calculate the estimates for the intercept and slope, using the WT equation (2.3), the BC equation (2.8), the IMP equation (2.10), and the regression method. In the regression method, we consider three different approaches to estimate E{Q i |V H i (u)}: (1) using the sample average of
only from observations with X i > u, conditioning on the treatment at each time u (denoted as AVE); (2) fitting an LRG for
only from observations with X i > u, combining all the censoring points and using treatment as the covariate (denoted as LRG); (3) fitting a generalized additive model for
only from observations with X i > u by smoothing on the Q i (u) (denoted as SM). Tables 1 and 2 are results from the two simulation experiments, respectively. The sample standard errors (SSE), the estimated standard errors (ESE), and the sample coverage probabilities (CP) of the true parameters by the 95% confidence intervals of those estimators are given. We also calculate the estimates if we use the true E{Q i |V H i (u)} (denoted as TrueE), since in the simulation we know the true distributions hence E{Q i |V H i (u)} can be obtained. However, in practice, this estimator cannot be used since we do not know the true expectation of Q i given the health history process V H i (u). From the results of our simulation studies, we can see that the biases for all the estimators are rather small, indicating that all the estimating equations give consistent estimates of the regression coefficients. The empirical sample variances are very close to the estimated variances from formula (2.12). The estimators LRG and AVE have bigger SSE than the simple weighted estimator. Using the smoothing approach, smoothing model (SM) does not improve the efficiency. As expected from the theory, plugging in the true expectation gives us the most efficient estimator. The IMP estimator performs the best among all the estimators not using the true expectation. When the sample size is 100, the coverage probability for the BC estimator is not very accurate, but it improves considerably as sample size increases. The coverage probabilities for all other estimators are very close to 0.95 even for small sample sizes.
APPLICATION
In the IBCSG Trial V, each patient experienced in sequence three health states: TOX (toxicity), TWiST (perfect health), and REL (disease relapse). We illustrate our methods with the quality-of-life coefficients q TOX = q REL = 0.5 and the time limit L = 84 (months). The amount of censoring is 29.3%. Similar to Cole and others (1993), we consider six covariates recorded from each patient upon enrollment in the study: treatment group (0 = short duration, 1 = long duration); tumor size (0 = less than 2 cm, 1 = at least 2 cm); logarithm of age; medium tumor grade (0 = not medium grade, 1 = medium grade); high tumor grade (0 = not high grade, 1 = high grade); number of nodes involved (0 = fewer than 4, 1 = at least 4). As in Cole and others (1993) , 94 patients are removed from the data due to missing values for tumor grade. Thus, there are 1135 patients included in the analysis and at L = 84 months, 363 patients are still at risk. We first considered a linear model with the six covariates and the interaction terms between treatment (treat) and the other covariates-tumor size (tsize), medium tumor grade (mgrade), high tumor grade (hgrade), and number of nodes involved (nodegrp). However, none of the interaction terms are significant; thus, they are excluded from our final model. We calculate the estimators using the WT estimating equation (2.3), the IMP estimating equation (2.10), the BC estimating equation (2.8), and other regression approaches for estimating E{Q i |V H i (u)}: the linear regression approach (LRG), the sample average approach conditioning on the treatment (AVE), and the generalized additive model with Q i (u) being the only regressor in the SM. Table 3 shows the results.
Concentrating on the covariate estimates and their standard errors first, we see that the AVE approach which estimates the expectation of Q i |V H i (u) by using the sample average for each treatment group at each censoring time does not perform well. The estimated standard error is bigger than all other approaches. The LRG approach, which is similar to AVE but combines all the censoring points together, performs slightly better. For some covariates, the SM approach produces a smaller standard error, but it is bigger for other covariates. BC estimator is consistently better than WT, but the improvement is not very big. The best performing estimator is the IMP estimator, similar as what we see in the simulation study.
We have also considered two other generalized additive models: smoothing Q i (u) with both treatment and Q i (u) as the regressors in the model, and smoothing Q i (u) with all the six covariates and Q i (u) as the regressors in the model. We found out that adding more regressors in the smoothing method did not make much difference, so the results from those two models are not included in Table 3 . Using the estimates from the IMP approach, we find that all six covariates are significant. A subject who is older, who has smaller tumor size, smaller number of nodes involved, lower tumor grade, and who is on the long-duration arm, has a longer expected QAL. This finding agrees with the description provided in the caption of Table 1 of Cole and others (1993) . Similar as Cole and others (1993) , a sensitivity analysis can be carried out with varying values of q TOX and q REL . For any fixed values for covariates, a treatment option can be chosen based on different quality-of-life utility values.
CONCLUSION AND DISCUSSION
In this paper, we have developed methods on how to estimate the covariate effects on the mean QAL, and how to obtain more efficient estimating equations. The theory developed by Robins and Rotnitzky (1992) provides the key to finding the form of the most efficient estimating equation, however, it is a function of the health history and cannot be estimated nonparametrically. We have examined different approaches for obtaining consistent estimators for regression coefficients.
We have assumed that the quality-of-life coefficient q is fixed in our methods. However, in a real application, q is often not known and has to be chosen from the quality-of-life questionnaires. A lot of research has been devoted to this area. There are instruments developed which can translate health states into quality-of-life coefficients. In the cases similar to our example when the number of health states are limited, we can perform a sensitivity analysis and find out the treatment advantages for each set of utility values.
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The simulation studies show that the best performing estimator is the IMP estimator using Q i (u) in place of E{Q i |V H i (u)}. The estimators using regression method (linear regression, or additive models) do not perform well. The BC estimator should always have smaller variance than the simple weighted estimator from the large sample theory, however, the improvement is not very big from our simulation studies.
We have assumed that censoring is independent of the health history process. If this assumption is not true, and censoring depends on some known covariates, we can accommodate this situation by fitting a Cox proportional hazards model to estimate the censoring distribution. If the Cox regression model is true, we can still get consistent estimators for the regression coefficients.
From Robins and Rotnitzky (1992) , h(Z ) can be optimized to improve the efficiency of the estimating equation. However, optimizing h involves estimating the second moments of Q i which will introduce some extra variability. How much more efficiency we may gain if we try to obtain the optimized h will be a subject of future research.
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whereˆ is a consistent estimator for = Cov(W 1 , W 2 )Var(W 2 ) −1 and can be obtained as follows. Since
it can be estimated consistently by
where J (X · Y ) for any random variables X and Y is defined in (2.9).
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Next, [G{Z Q Q(u), u} − G{Q(u), u}G(Z Q, u) ]
It can be estimated consistently by
Using these results, the estimating equation (A.1) can be written as
from which the BC estimator can be obtained easily and shown in (2.8).
